 |
|
|
| |
Combined effect of obeticholic acid and bezafibrate in patients with primary biliary cholangitis and inadequate response or intolerance to ursodeoxycholic acid: 6-month results from a phase 2 trial
|
| |
| |
EASL 2024 June 5-8
David Jones,1 Alexandre Louvet,2 Christophe Corpechot,3 Vaclav Hejda,4 Heng Zou,5 Antonio Civitarese,5 Alejandra Villamil,6 Frederick Nevens7
|
| |
|
|
|
|
|
